# Test Results: fundamentals/chain-of-thought.md

> ⚠️  Raw model output captured automatically by the cross-model test harness on 2026-06-23.
> This output is **not yet verified**. An author must read the output and set the
> assessment below before this counts as a tested result (see CLAUDE.md, Hard Rules).

## Test Metadata
- **Prompt:** fundamentals/chain-of-thought.md
- **Model:** claude-sonnet-4.6
- **Model ID (pinned):** claude-sonnet-4-6
- **Endpoint:** native
- **Date:** 2026-06-23
- **Tester:** cross-model-harness
- **Assembly strategy:** concat
- **Temperature:** 0.0

## Test Input Used
Standard test input from prompt file (`## Test Input`).

## Filled Prompt
```
{TASK_DESCRIPTION}

Think through this step by step:
1. First, identify {RELEVANT_FACTORS}
2. Then, consider {KEY_CONSIDERATIONS}
3. Finally, {REACH_CONCLUSION}

Show your reasoning at each step before providing your final answer.

I need to select a statistical approach for analyzing my microbiome data. Here's my study:

- 20 mice, 10 per treatment group (probiotic vs. placebo)
- Fecal samples collected at 3 time points (days 0, 14, 28)
- Outcome: relative abundances of bacterial taxa (compositional data)
- Question: Does probiotic treatment affect community composition over time?
- Additional context: Some mice were co-housed (2-3 per cage), creating potential cage effects

Think through this step by step:

**Step 1 - Data structure:**
What are the key features of my data that affect analysis choice? Consider the experimental design, the nature of the outcome variable, and any dependencies in the data.

**Step 2 - Candidate approaches:**
What statistical approaches could address my question? For each, briefly note what it assumes and what it tests.

**Step 3 - Assumption evaluation:**
For each candidate approach, which assumptions might be problematic for my specific data structure?

**Step 4 - Practical considerations:**
What practical factors (software availability, interpretability, field conventions) should influence the choice?

**Step 5 - Recommendation:**
Based on the above, what approach or approaches would you suggest I discuss with a statistician? What specific questions should I ask them?

Show your reasoning explicitly at each step.
```

## Model Output
```
# Statistical Approach Selection for Microbiome Data

## Step 1 — Data Structure Analysis

Let me identify the key features that constrain the analysis:

**Experimental design features:**
- **Repeated measures**: Same 20 mice measured at 3 time points → observations within a mouse are correlated; this is not ignorable
- **Two-level nesting**: Mice are nested within cages (2–3 per cage), and cages are nested within treatment groups → a second correlation structure exists
- **Small n**: 10 mice/group means roughly 4–5 cages/group (assuming ~2.5 mice/cage), so cage-level replication is limited
- **Balanced design**: Equal group sizes is helpful, but the cage structure may be unbalanced

**Outcome variable features:**
- **Compositional data**: Relative abundances sum to 1 (or 100%) — this is a hard constraint, not just a distributional preference
- Compositional data live in a **simplex**, not Euclidean space; standard Euclidean-based methods are technically inappropriate without transformation
- **High dimensionality**: Likely dozens to hundreds of taxa, many with zero counts (sparse)
- **Non-normal distributions**: Relative abundances are typically zero-inflated and right-skewed

**The core statistical challenge in one sentence:**
> You have compositional, high-dimensional, repeated-measures data with two levels of clustering (mouse, cage), and your treatment is assigned at the cage level — making cage the true unit of randomization.

---

## Step 2 — Candidate Approaches

I'll organize these by what level of the data they address:

### 2A. Community-level (multivariate) approaches
These ask: *Does the overall community differ?*

| Approach | What it tests | Key assumptions |
|---|---|---|
| **PERMANOVA** (adonis2 in vegan) | Differences in centroid/dispersion of distance matrix between groups | Exchangeability of units under H₀; handles any distance metric |
| **PERMDISP** | Differences in *dispersion* (variance) rather than location | Complement to PERMANOVA; tests a different null |
| **MANOVA / db-RDA** | Linear multivariate differences; constrained ordination | Multivariate normality (MANOVA); linearity |
| **Mixed-effects multivariate models** | Group × time effects with random effects | More parametric; computationally intensive |

### 2B. Taxon-level (univariate) approaches
These ask: *Which specific taxa differ?*

| Approach | What it tests | Key assumptions |
|---|---|---|
| **DESeq2 / edgeR** | Differential abundance per taxon | Negative binomial counts; size-factor normalization |
| **ANCOM-BC** | Differential abundance with bias correction | Sparse log-normal; handles compositionality explicitly |
| **MaAsLin2** | Multivariable association per taxon | Linear/log-linear models; handles random effects |
| **ALDEx2** | Differential abundance via CLR + Dirichlet sampling | Compositional; Bayesian uncertainty propagation |

### 2C. Diversity approaches
These reduce the community to scalar summaries:

| Approach | What it tests | Key assumptions |
|---|---|---|
| **Alpha diversity (LMM)** | Within-sample richness/evenness over time | Normality of diversity metric; handles repeated measures |
| **Beta diversity trajectories** | Change in community distance over time | Requires careful distance metric choice |

---

## Step 3 — Assumption Evaluation

This is where your specific data structure creates real problems:

### 🔴 Critical problem: Cage is the unit of randomization

Treatment was assigned to cages, not individual mice. This means:

- **Mice within a cage are pseudoreplicates** for the treatment effect
- The effective sample size for testing treatment is the **number of cages** (~4–5 per group), not the number of mice (10 per group)
- Ignoring cage effects **inflates Type I error** — you may find "significant" treatment effects that are actually cage effects

> **This is the single most important issue in your design.** Many microbiome papers get this wrong.

### 🔴 Critical problem: Compositionality

Standard PERMANOVA with Bray-Curtis dissimilarity is common but:
- Bray-Curtis operates on relative abundances directly, which are not independent
- The **Aitchison distance** (Euclidean distance on CLR-transformed data) is theoretically more appropriate for compositional data
- Using inappropriate distances can distort the geometry of your data

### 🟡 Moderate problem: Repeated measures in PERMANOVA

Standard PERMANOVA (`adonis2`) does **not** natively handle repeated measures or random effects. Options:
- `lme4`-based permutation schemes
- `vegan::adonis2` with strata argument (partial permutation — imperfect)
- Dedicated tools like `PERMANOVA+` (commercial) or `glmmTMB` for taxon-level models

### 🟡 Moderate problem: Small cage-level n

With ~4–5 cages per group:
- Random effects for cage will be estimated with high uncertainty
- Some methods (e.g., REML-based LMMs) may struggle to partition variance reliably
- Permutation-based methods may have limited power

### 🟡 Moderate problem: Multiple testing

Testing hundreds of taxa simultaneously requires correction (FDR/Benjamini-Hochberg), but standard corrections assume independence — which your data violates due to compositionality and correlation structure.

### 🟢 Less problematic: Time points

Three time points is manageable. You can model time as:
- **Categorical** (days 0, 14, 28) — flexible, no shape assumption
- **Continuous** — assumes linear or smooth trajectory
- The key question is whether you expect a **treatment × time interaction** (trajectories diverge) or just a **main effect of treatment**

---

## Step 4 — Practical Considerations

| Factor | Consideration |
|---|---|
| **Field conventions** | PERMANOVA + ordination (PCoA/NMDS) is expected in microbiome papers; reviewers will ask for it even if it's not optimal |
| **Software** | R ecosystem is mature: `vegan`, `phyloseq`, `MaAsLin2`, `ANCOM-BC`, `ALDEx2`, `lme4`, `glmmTMB` all freely available |
| **Interpretability** | Community-level results (ordination plots) are intuitive; taxon-level results are more actionable but require multiple testing correction |
| **Reproducibility** | Permutation-based methods require setting seeds; document this |
| **Compositionality tools** | `ALDEx2` and `ANCOM-BC` are increasingly standard and handle compositionality; `DESeq2` is borrowed from RNA-seq and its assumptions are debated for microbiome |

---

## Step 5 — Recommended Approach

### My suggested analytical framework (to discuss with a statistician):

```
Primary question: Does treatment affect community composition over time?
│
├── Community level (required for publication)
│   ├── Aitchison distance (CLR-based) OR Bray-Curtis (conventional)
│   ├── PCoA ordination — visualize trajectories
│   └── PERMANOVA with cage as blocking factor
│       └── ⚠️ Ask statistician: how to properly handle
│           repeated measures + cage random effect
│
├── Diversity level (secondary)
│   ├── Alpha diversity ~ treatment * time + (1|cage/mouse)
│   └── Linear mixed model in lme4
│
└── Taxon level (exploratory/mechanistic)
    ├── MaAsLin2 — handles random effects for cage + mouse
    ├── ANCOM-BC — compositionally aware
    └── Report with FDR correction; treat as hypothesis-generating
```

### Specific questions to ask your statistician:

**On the cage effect (highest priority):**
1. *"Given that treatment was assigned at the cage level, should cage be treated as a fixed or random effect, and does this change my effective sample size for the treatment test?"*
2. *"Is there a valid permutation scheme for PERMANOVA that accounts for both the cage clustering and the repeated measures structure simultaneously?"*

**On compositionality:**
3. *"Should I use Aitchison distance instead of Bray-Curtis, and does this change my conclusions in practice with this dataset?"*
4. *"For taxon-level analysis, which method — MaAsLin2, ANCOM-BC, or ALDEx2 — best handles my combination of repeated measures, cage effects, and compositional constraints?"*

**On the time component:**
5. *"Should I model the treatment × time interaction, or test treatment effect averaged across time points? What are the power implications given my small cage n?"*
6. *"Is day 0 (baseline) expected to differ between groups? If not, should I use a baseline-adjusted model or include it as a covariate?"*

**On power:**
7. *"With ~4–5 cages per group as my true replication unit, am I adequately powered to detect a treatment effect? Should I report a post-hoc power analysis?"*

---

### Bottom line recommendation:

> Use a **two-analysis strategy**: (1) community-level PERMANOVA with Aitchison distance, with cage properly accounted for, plus ordination visualization; and (2) taxon-level MaAsLin2 with cage and mouse as nested random effects. The cage effect is your most urgent methodological concern — if it's ignored, your treatment p-values are not trustworthy regardless of which distance metric you choose.
```

## Assessment
_To be completed by a human reviewer. Do not mark Pass without reading the output._

### Task Achievement
- **Achieved:** [Yes / No / Partial]
- **Notes:**

### Constraint Compliance
- **All constraints respected:** [Yes / No]
- **Violations noted:**

### Failure Modes
- **Failure modes observed:** [None / list]
- **Mitigation effectiveness:**

### Output Format
- **Format correct:** [Yes / No]
- **Deviations:**

## Overall Assessment
- **Recommendation:** PENDING AUTHOR REVIEW
- **Notes:**

## Verification Steps Tested
_Which verification requirements from the prompt were checked, and results._
